Option Care Health (NASDAQ:OPCH) Cut to “Hold” at Jefferies Financial Group

Jefferies Financial Group cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a hold rating in a research report released on Thursday morning, MarketBeat.com reports. The brokerage currently has $26.00 target price on the stock, down from their prior target price of $38.00.

Several other research firms have also weighed in on OPCH. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research report on Wednesday. Barrington Research reissued an “outperform” rating and set a $40.00 price objective on shares of Option Care Health in a research report on Wednesday, October 23rd. Finally, JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.60.

Option Care Health Stock Up 4.6 %

NASDAQ OPCH opened at $24.11 on Thursday. Option Care Health has a 1 year low of $22.84 and a 1 year high of $34.63. The stock has a market capitalization of $4.10 billion, a PE ratio of 20.26, a PEG ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36. The business’s 50-day moving average is $30.49 and its 200 day moving average is $29.91.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.22 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Sell-side analysts forecast that Option Care Health will post 1.23 earnings per share for the current year.

Insiders Place Their Bets

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Institutional Trading of Option Care Health

Large investors have recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the last quarter. SageView Advisory Group LLC purchased a new stake in shares of Option Care Health during the 1st quarter valued at about $85,000. Finally, International Assets Investment Management LLC lifted its holdings in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.